{"meta":{"query_hash":"dcb8de39aacb","filters":{"venue":"Degenerative Neurological and Neuromuscular Disease"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/dcb8de39aacb","api":"https://metacan.xera.ac/api/v1/cohort?venue=Degenerative+Neurological+and+Neuromuscular+Disease"},"results":[{"id":"W1859536052","doi":"10.2147/dnnd.s48420","title":"Current and emerging treatment options for spinal muscular atrophy","year":2015,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Spinal muscular atrophy; Medicine; Current (fluid); Physical medicine and rehabilitation; Atrophy; Neuroscience; Pathology; Psychology; Disease; Engineering","score_opus":0.1445036446927771,"score_gpt":0.41938417288108176,"score_spread":0.27488052818830466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1859536052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001559716,0.9980585,0.0001562214,0.00033959703,0.00017707539,0.000004876825,0.000023443436,0.0000100545985,0.0010742213],"genre_scores_gemma":[0.0009451093,0.9977549,0.00031120793,0.0002349999,0.00016838724,0.0000072953267,0.00004086405,0.0000014559338,0.0005358613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998479,0.000023812825,0.000027288317,0.000027820373,0.0000588153,0.000014412237],"domain_scores_gemma":[0.99979466,0.000101299986,0.00003427524,0.0000052159603,0.000049235758,0.000015233846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004248579,0.00058835023,0.0008902323,0.0018922368,0.00028579138,0.0006802405,0.0006485837,0.0008143325,0.0049303556],"category_scores_gemma":[0.00054379686,0.00014635577,0.0005712158,0.0009848638,0.00028331528,0.00093412556,0.0005043196,0.0014092443,0.0016923371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054759632,0.00006537327,0.00014645328,0.014018627,0.000074083204,0.00024838455,0.00004396792,0.00022518136,0.0019500958,0.0028575887,0.019298622,0.9610168],"study_design_scores_gemma":[0.000028125689,0.00014738606,0.0010558617,0.008560869,0.00020675754,0.00328515,0.00011309333,0.00014264822,0.0008899064,0.0030659302,0.9824812,0.000023065086],"about_ca_topic_score_codex":0.00053376507,"about_ca_topic_score_gemma":0.0012931401,"teacher_disagreement_score":0.0049303556,"about_ca_system_score_codex":0.0003349121,"about_ca_system_score_gemma":0.0006244926,"threshold_uncertainty_score":0.016493678},"labels":[],"label_agreement":null},{"id":"W2023509561","doi":"10.2147/dnnd.s40349","title":"Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA","year":2014,"lang":"en","type":"article","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Overactive bladder; Spinal cord injury; Medicine; Multiple sclerosis; Spinal cord; Urology; Pathology; Psychiatry","score_opus":0.035313223653624985,"score_gpt":0.2870808102207711,"score_spread":0.2517675865671461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023509561","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01619541,0.9721043,0.0004035239,0.00653802,0.00040073015,0.000012192364,0.000016927728,0.000010252929,0.0043186727],"genre_scores_gemma":[0.1142318,0.87791836,0.0013078012,0.0026626566,0.0014919898,0.000023224988,0.000034105786,0.0000055942864,0.0023244743],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99983156,0.000056456378,0.000024896648,0.000016338838,0.000047401554,0.000023303188],"domain_scores_gemma":[0.9996251,0.00017834759,0.000105952924,0.000005006005,0.000048603662,0.000037016576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049627834,0.0002552952,0.0005129087,0.00044969958,0.00030778386,0.00054950983,0.00024744534,0.0007862374,0.0013608115],"category_scores_gemma":[0.00074784626,0.00006623052,0.000343166,0.00031604918,0.00042640377,0.00047263294,0.0004842429,0.00079246506,0.00020653645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009973762,0.00026675555,0.019558601,0.007462871,0.00041359157,0.00815324,0.0003678256,0.0006377037,0.014060491,0.004229716,0.014810485,0.9290414],"study_design_scores_gemma":[0.0006952631,0.003763257,0.19928254,0.017726276,0.001298411,0.15850264,0.0019690471,0.0025222402,0.015128268,0.010077556,0.58888704,0.00014744564],"about_ca_topic_score_codex":0.0010497731,"about_ca_topic_score_gemma":0.0022199042,"teacher_disagreement_score":0.0013608115,"about_ca_system_score_codex":0.0006155123,"about_ca_system_score_gemma":0.000617949,"threshold_uncertainty_score":0.0045523643},"labels":[],"label_agreement":null},{"id":"W2035586497","doi":"10.2147/dnnd.s34160","title":"The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration","year":2013,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Neuroscience; Affect (linguistics); Pathophysiology; Psychology; Medicine; Neuroimaging; Psychiatry; Internal medicine","score_opus":0.06466464101282918,"score_gpt":0.3086984988233055,"score_spread":0.24403385781047635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035586497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021476646,0.9992887,0.000035738267,0.00012291037,0.00003041035,0.0000016433942,0.000008042425,0.0000016414505,0.0002960749],"genre_scores_gemma":[0.0014766423,0.99823064,0.000082261344,0.000051712792,0.000059013048,0.000002215797,0.000011704665,3.6760719e-7,0.00008541762],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997788,0.000047369274,0.000054077755,0.00004004528,0.000058350615,0.000021319467],"domain_scores_gemma":[0.99965274,0.00015562862,0.00009527714,0.0000069378784,0.00007076608,0.00001855899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041633353,0.0007639567,0.0011687591,0.0030943423,0.00028856518,0.00087799184,0.0006049068,0.0009441669,0.0014978867],"category_scores_gemma":[0.0010724488,0.00024735148,0.0005178978,0.0027061289,0.00056485366,0.0011358432,0.0005358209,0.0007739003,0.00044463802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009238656,0.0000552834,0.0033004584,0.034057118,0.0002576234,0.0017449429,0.00024571794,0.00042874957,0.001228096,0.003426691,0.014636739,0.94052625],"study_design_scores_gemma":[0.000050676954,0.0002335192,0.041840307,0.050475325,0.0014172066,0.07050448,0.0011414811,0.0004909349,0.0016376642,0.009334628,0.8227575,0.00011634339],"about_ca_topic_score_codex":0.0030131524,"about_ca_topic_score_gemma":0.0040916335,"teacher_disagreement_score":0.0030943423,"about_ca_system_score_codex":0.00072866224,"about_ca_system_score_gemma":0.0014712582,"threshold_uncertainty_score":0.00599128},"labels":[],"label_agreement":null},{"id":"W2044209898","doi":"10.2147/dnnd.s70079","title":"Use of transcranial magnetic stimulation in the treatment of selected movement disorders","year":2014,"lang":"en","type":"article","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Transcranial magnetic stimulation; Physical medicine and rehabilitation; Movement disorders; Medicine; Stimulation; Movement (music); Neuroscience; Psychology; Internal medicine; Physics","score_opus":0.04214995891808099,"score_gpt":0.24891529098497003,"score_spread":0.20676533206688905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044209898","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051343538,0.9371337,0.0024934297,0.0008058908,0.0002567206,0.000085851985,0.000065107764,0.000035492387,0.0077803098],"genre_scores_gemma":[0.26828614,0.7232051,0.00510236,0.00081008056,0.0006560883,0.00015330118,0.00011394191,0.00001582827,0.0016571663],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999718,0.000121658864,0.000034215296,0.000042146745,0.00006726179,0.00001677163],"domain_scores_gemma":[0.9998061,0.00012138204,0.000029552908,0.000009791247,0.000023440203,0.000009673918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007572511,0.00032651046,0.0006168778,0.00068299443,0.00019765034,0.0003148132,0.0003699843,0.0004468669,0.0014972399],"category_scores_gemma":[0.00075973285,0.00006741522,0.00037555583,0.00060766574,0.00029395576,0.000263346,0.00018516394,0.0004987255,0.00034369918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016421633,0.0005425735,0.0016551565,0.009055927,0.0003578539,0.0013805894,0.00025229075,0.00030762094,0.057264958,0.001512652,0.0021605024,0.9238677],"study_design_scores_gemma":[0.003231707,0.054224502,0.12108191,0.012891193,0.0033648994,0.05487469,0.0011879537,0.0017715978,0.14908716,0.007337689,0.59074676,0.00019990762],"about_ca_topic_score_codex":0.00061613566,"about_ca_topic_score_gemma":0.0012849584,"teacher_disagreement_score":0.0014972399,"about_ca_system_score_codex":0.00022499313,"about_ca_system_score_gemma":0.00028910712,"threshold_uncertainty_score":0.005008757},"labels":[],"label_agreement":null},{"id":"W2555671962","doi":"10.2147/dnnd.s87323","title":"Respiratory management of patients with neuromuscular disease: current perspectives","year":2016,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Neuromuscular disease; Weakness; Medicine; Respiratory failure; Respiratory system; Intensive care medicine; Disease; Muscle weakness; Physical medicine and rehabilitation; Physical therapy; Internal medicine; Surgery","score_opus":0.032804646879167086,"score_gpt":0.3002633819016569,"score_spread":0.26745873502248985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555671962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079626196,0.99885833,0.00005584532,0.0004228149,0.00014018212,0.0000018059216,0.000008577506,0.000003464535,0.0004293369],"genre_scores_gemma":[0.00080169947,0.9983852,0.00013453265,0.00025644866,0.00027578074,0.0000028529248,0.000016356875,8.0919324e-7,0.00012623033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997569,0.000047272155,0.00006268823,0.000041760642,0.00007245505,0.000018924766],"domain_scores_gemma":[0.99941087,0.0003305491,0.000090577116,0.000010364528,0.00012407514,0.000033716813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055093894,0.00067996705,0.0010873838,0.0016660161,0.00028106343,0.0009800895,0.00075457676,0.0011556305,0.0029568977],"category_scores_gemma":[0.0013706236,0.00018865026,0.000599353,0.0012770765,0.00037091025,0.0015187229,0.0005618792,0.0016742687,0.0009935962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067167304,0.0000639574,0.00051358173,0.029508406,0.00012317135,0.0005545318,0.00012746053,0.000311728,0.00064315804,0.0018718082,0.028255632,0.9379594],"study_design_scores_gemma":[0.000034305922,0.00013486246,0.0030101414,0.039896842,0.0004422767,0.010563104,0.0003399407,0.00022276428,0.0003022959,0.0032979227,0.94171107,0.00004445511],"about_ca_topic_score_codex":0.00097537,"about_ca_topic_score_gemma":0.0019058216,"teacher_disagreement_score":0.0029568977,"about_ca_system_score_codex":0.00045362936,"about_ca_system_score_gemma":0.000888019,"threshold_uncertainty_score":0.009891808},"labels":[],"label_agreement":null},{"id":"W2599002181","doi":"10.2147/dnnd.s71986","title":"Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a","year":2017,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cameco (Canada); Innovation Cluster (Canada); University of Saskatchewan","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada; Saskatchewan Health Research Foundation","keywords":"Multiple sclerosis; Medicine; PEGylation; Neuroinflammation; Pegylated interferon; Neurodegeneration; Interferon beta-1b; Immunology; Clinical trial; Pharmacology; Disease; Internal medicine; Interferon beta; Polyethylene glycol; Ribavirin; Biology; Hepatitis C virus","score_opus":0.22598482052524857,"score_gpt":0.3864206091049136,"score_spread":0.16043578857966503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599002181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008588396,0.9993424,0.000041556603,0.00014225124,0.00005296039,0.0000023422417,0.000009506058,0.0000028600725,0.00032021187],"genre_scores_gemma":[0.00061336847,0.9989875,0.00010096069,0.00009724252,0.000052638865,0.0000034207565,0.000012589152,7.0793214e-7,0.00013145586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997749,0.00004803087,0.000053733624,0.000035919846,0.00007135786,0.000016000802],"domain_scores_gemma":[0.99956113,0.0002536932,0.000065936205,0.000010991685,0.00008405147,0.000024232875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006587769,0.0005507258,0.0010984496,0.0022501468,0.00023664699,0.00067074125,0.0005687843,0.0008326735,0.0033217506],"category_scores_gemma":[0.00090761326,0.00016492259,0.00069061946,0.0017862228,0.00033624188,0.000905799,0.00047712063,0.0013671558,0.0009727385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010379819,0.0000675116,0.0001669724,0.033899955,0.00013535797,0.0001233442,0.000059102287,0.00018911198,0.0009971153,0.0020002627,0.011542811,0.9507145],"study_design_scores_gemma":[0.000040848714,0.00017629395,0.0015012019,0.014621876,0.00046186658,0.0016930861,0.00009847662,0.000097622345,0.0006799551,0.0017140325,0.9788937,0.000020952612],"about_ca_topic_score_codex":0.0010346855,"about_ca_topic_score_gemma":0.0017888373,"teacher_disagreement_score":0.0033217506,"about_ca_system_score_codex":0.00044122516,"about_ca_system_score_gemma":0.0009708021,"threshold_uncertainty_score":0.011112332},"labels":[],"label_agreement":null},{"id":"W2884841728","doi":"10.2147/dnnd.s146949","title":"Physical therapy for individuals with amyotrophic lateral sclerosis: current insights","year":2018,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Amyotrophic lateral sclerosis; Life expectancy; Medicine; Disease; Quality of life (healthcare); Health care; Occupational therapy; Rehabilitation; Physical disability; Physical therapy; Physical medicine and rehabilitation; Nursing","score_opus":0.10671201332363073,"score_gpt":0.35023809143367735,"score_spread":0.24352607811004662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884841728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045035384,0.9992949,0.000024040202,0.00026899102,0.00006427145,0.0000024993246,0.000008386236,0.0000020827426,0.0002897357],"genre_scores_gemma":[0.00037469802,0.9992754,0.00007159268,0.00011399365,0.00006317629,0.0000041433063,0.000009689717,5.689339e-7,0.00008673619],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995389,0.00010913889,0.00011090368,0.000073399184,0.0001419293,0.000025696434],"domain_scores_gemma":[0.998618,0.0009287079,0.0001653227,0.000023790817,0.00021199064,0.00005208185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010940243,0.0007050077,0.0012669247,0.0029545773,0.0003727148,0.0013639637,0.00092502125,0.0014525565,0.0039779413],"category_scores_gemma":[0.0027704597,0.0002637649,0.0007743384,0.0031702963,0.00059909374,0.0014511868,0.0008877884,0.0014326554,0.001306524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053746782,0.00006908797,0.00030100648,0.05566501,0.00013484005,0.00011017359,0.00017255865,0.0001108851,0.0002761619,0.0019242426,0.017323652,0.9238586],"study_design_scores_gemma":[0.000033479973,0.00013490499,0.0029907383,0.07432278,0.0006358204,0.0019641807,0.00041846372,0.00008999757,0.00021000652,0.0028838166,0.91628164,0.000034273697],"about_ca_topic_score_codex":0.0019909248,"about_ca_topic_score_gemma":0.0036589266,"teacher_disagreement_score":0.0039779413,"about_ca_system_score_codex":0.0006236947,"about_ca_system_score_gemma":0.0019418659,"threshold_uncertainty_score":0.013307571},"labels":[],"label_agreement":null},{"id":"W2953698201","doi":"10.2147/dnnd.s208815","title":"<p>Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials</p>","year":2019,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Randomized controlled trial; Intensive care medicine; Internal medicine; Psychiatry; Nursing","score_opus":0.17989305505061057,"score_gpt":0.3930955866060155,"score_spread":0.21320253155540494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953698201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010382861,0.99736917,0.00013973533,0.00044538575,0.000078719655,0.00039284638,0.00029423423,0.000007407333,0.00023421715],"genre_scores_gemma":[0.021109508,0.9750786,0.0012947049,0.00085689797,0.00015320415,0.0010560248,0.00035617835,0.000009158281,0.00008568579],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97715193,0.0072355485,0.009937102,0.0013673861,0.0038492593,0.00045867526],"domain_scores_gemma":[0.9085751,0.06323416,0.018589407,0.0009620463,0.007987293,0.00065191725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031835854,0.0022161407,0.012458428,0.016233707,0.0009081851,0.00415015,0.0027864035,0.0032291552,0.0053895777],"category_scores_gemma":[0.09194814,0.0014804665,0.016298631,0.015223202,0.0015039744,0.0034144141,0.0021843673,0.0017094658,0.000491174],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061075296,0.0000360968,0.0010316616,0.9247801,0.020906024,0.0000788035,0.00015978687,0.000087659835,0.00015968525,0.00016756656,0.0010136559,0.050968256],"study_design_scores_gemma":[0.0011094925,0.00054507435,0.0065589254,0.760204,0.21924107,0.0003843962,0.00036426436,0.00013829199,0.00031916425,0.0005016953,0.010575808,0.00005782785],"about_ca_topic_score_codex":0.004587268,"about_ca_topic_score_gemma":0.011313375,"teacher_disagreement_score":0.031835854,"about_ca_system_score_codex":0.00551154,"about_ca_system_score_gemma":0.012245882,"threshold_uncertainty_score":0.16836607},"labels":[],"label_agreement":null},{"id":"W2980119243","doi":"10.2147/dnnd.s180027","title":"<p>Orphan Drugs In Development For The Treatment Of Friedreich’s Ataxia: Focus On Omaveloxolone</p>","year":2019,"lang":"en","type":"article","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Coenzyme Q10 studies and effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Ataxia; Idebenone; Oxidative stress; Frataxin; Medicine; Pharmacology; Neuroscience; Internal medicine; Biology; Psychiatry; Iron-binding proteins","score_opus":0.01133972049844709,"score_gpt":0.2305556228567245,"score_spread":0.21921590235827743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980119243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14332584,0.70295393,0.009874496,0.016751211,0.0031298874,0.0010530675,0.0030704476,0.0008306207,0.119010516],"genre_scores_gemma":[0.37604544,0.48077938,0.018651024,0.0074388715,0.0025681672,0.00061525404,0.0019731312,0.00020414506,0.11172462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999269,0.000015974554,0.0000074700633,0.000016323324,0.00001602231,0.000017243234],"domain_scores_gemma":[0.99985814,0.00002453512,0.000038872604,0.000009390857,0.000029845816,0.00003925258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004048553,0.00053937704,0.00035555387,0.00042209585,0.00019719893,0.0004490727,0.0003321388,0.00055430736,0.01353602],"category_scores_gemma":[0.00014211671,0.000096541095,0.00027779673,0.00031413985,0.0003485958,0.00043877756,0.00034117012,0.0010617812,0.002511682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028607303,0.0010757798,0.0008547192,0.0039054665,0.000095238254,0.00073715806,0.000080572834,0.0003809334,0.2083638,0.00723651,0.024113435,0.7502957],"study_design_scores_gemma":[0.002308106,0.019964619,0.007936719,0.0016361462,0.0003443638,0.0034210798,0.0001362464,0.00071420695,0.15735163,0.003265789,0.8028633,0.000057758833],"about_ca_topic_score_codex":0.0005881147,"about_ca_topic_score_gemma":0.002001238,"teacher_disagreement_score":0.01353602,"about_ca_system_score_codex":0.00028687596,"about_ca_system_score_gemma":0.00053336506,"threshold_uncertainty_score":0.045282423},"labels":[],"label_agreement":null},{"id":"W4409365773","doi":"10.2147/dnnd.s495536","title":"Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies","year":2025,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Duchenne muscular dystrophy; Genome editing; Muscular dystrophy; Medicine; Computer science; Computational biology; Gene; Biology; CRISPR; Genetics; Internal medicine","score_opus":0.031093457627698287,"score_gpt":0.33194634593768285,"score_spread":0.3008528883099846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409365773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012985861,0.99802893,0.0003661888,0.00023864917,0.00016644038,0.000006119354,0.000019440035,0.00001856489,0.0010258883],"genre_scores_gemma":[0.00062450685,0.9982305,0.00033819716,0.00017741341,0.00009316516,0.000010439273,0.00002957536,0.0000031478467,0.0004931152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997483,0.00004520361,0.000028251492,0.00004503013,0.00010788875,0.000025407422],"domain_scores_gemma":[0.9997296,0.00015226647,0.00002836551,0.000011462647,0.00005070568,0.000027616063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084277795,0.00091452006,0.0013648369,0.002239537,0.00023294211,0.0010246373,0.0010966982,0.001212552,0.0029955122],"category_scores_gemma":[0.00065914204,0.00036821596,0.0005595304,0.0014592905,0.00067322614,0.0013517309,0.00079655537,0.0023405722,0.0017732742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009097643,0.000121841775,0.0001062359,0.018496726,0.00010913216,0.00027255408,0.000089000416,0.00066124013,0.007178711,0.011679628,0.03345226,0.9277416],"study_design_scores_gemma":[0.000021009775,0.000110255554,0.000314262,0.0025821242,0.00006995789,0.00079270895,0.00003263913,0.000109194596,0.0010348181,0.0029203324,0.9919922,0.00002043816],"about_ca_topic_score_codex":0.00073700526,"about_ca_topic_score_gemma":0.0010688927,"teacher_disagreement_score":0.0029955122,"about_ca_system_score_codex":0.0007145828,"about_ca_system_score_gemma":0.00090689835,"threshold_uncertainty_score":0.010021031},"labels":[],"label_agreement":null}]}